deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL 5-arm NCT04700423

Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration

Efficacy and Safety of Moxidectin and Albendazole Compared to Ivermectin and Albendazole Co-administration in Adolescents Infected With Trichuris Trichiura: a Randomized Controlled Trial

Sponsor: Jennifer Keiser

Conditions Ascariasis Helminthes; Infestation, Intestinal Hookworm Infections Trichuriasis
Interventions ALBENDAZOLE 400 Mg ORAL TABLET [ZENTEL] ivermectin (200 µg/kg) ivermectin (200 µg/kg) / albendazole (400 mg) moxidectin (8 mg) moxidectin (8 mg) / albendazole (400 mg)
Updated 6 times since 2021 Last updated: Nov 26, 2024 Started: Mar 1, 2021 Primary completion: Aug 18, 2021 Completion: Sep 22, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04700423, this PHASE2/PHASE3 trial focuses on Ascariasis and Helminthes; Infestation, Intestinal and remains completed. Sponsored by Jennifer Keiser, it has been updated 6 times since 2021, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Feb 2021 – ~Oct 2021 · 8 months · monthly snapshotNot Yet Recruiting~Oct 2021 – ~Feb 2022 · 4 months · monthly snapshot~Feb 2022 – ~Jul 2024 · 29 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshot~Jan 2025 – present · 18 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Jan 2025 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Sep 2024 — Jan 2025 [monthly]

    Completed PHASE2/PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  4. Feb 2022 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

    Status: Not Yet Recruiting → Completed

  5. Oct 2021 — Feb 2022 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

▶ Show 1 earlier version

  1. Feb 2021 — Oct 2021 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Jennifer Keiser
  • Public Health Laboratory Ivo de Carneri
Data source: Swiss Tropical & Public Health Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations